Hannah Valantine has an estimated net worth of $3.52 Million. This is based on reported shares across multiple companies, which include CareDx, Inc., PACIFIC BIOSCIENCES OF CALIFORNIA, INC., and BridgeBio Pharma, Inc..
2021 was Hannah Valantine's most active year for acquiring shares with 12 total transactions. Hannah Valantine's most active month to acquire stocks was the month of May. 2025 was Hannah Valantine's most active year for disposing of shares, totalling 11 transactions. Hannah Valantine's most active month to dispose stocks was the month of May. 2025 saw Hannah Valantine paying a total of $1,522,247.05 for 134,768 shares, this is the most they've acquired in one year. In 2025 Hannah Valantine cashed out on 100,579 shares for a total of $2,684,800.42, their largest year based on trade value.